A giant in flavors and fragrances... struggling to stay efficient

Today I'm digging into International Flavors and Fragrances (IFF).

IFF formulates and manufactures the tastes, textures, and scents inside thousands of products.

A few things that jumped out to me:

• A $17B business that sells flavors and smells...who would have guessed?!

• IFF has generated essentially no operating profit over the last few years in total. They did produce $1B in operating cash flow in 2024, but their income statement has been marred with M&A-related impairments and write-downs.

• For some reason given the cool niche-y nature of this business, I expected them to be more profitable than they are. To me, it seems like IFF would have a lot of intellectual property that would be able to generate a gross margin greater than 50%, but they are quite a ways away from that.

The positive news is that IFF has finally started cleaning house. They have sold non-core units, paid down billions in debt, and refocused on the parts of the business that actually generate value.

Their gross margin has improved from 17% from 2023 to the TTM period. That increases to simplifying operations, consolidating plants, and rethinking how they price through inflation.

Here are two actionable takeaways:

• Focus beats scale. Adding more products or acquisitions does not guarantee margin. Simplify your operating model before you complicate it.

• Build applications and demos into your sales motion. IFF wins more deals when customers can taste, test, and iterate fast. Speed plus experience increases close rates.

This was a fun one to take a look at. If you like these reports, I'd love if you shared them onto a friend!

With that, I'll see you tomorrow!

Nick

TL;DR

• IFF supplies the taste, scent, texture, and functional ingredients behind food, beverage, home and personal care, and pharma products.

• After a debt-heavy acquisition streak and the 2021 DuPont Nutrition & Biosciences merger, IFF has been pruning assets, paying down debt, and repairing margins.

• The playbook to copy is customer-embedded R&D and rapid application labs that turn briefs into spec'd-in products with sticky, recurring demand.

• The cautionary tale is leverage and integration risk. Expansion without dry powder forces divestitures and covenant gymnastics.

The 30,000-Foot View

• Business model: B2B ingredients plus co-creation. IFF co-develops flavors, fragrances, enzymes, cultures, texturizers, and excipients, then supplies under multi-year relationships that reward speed, regulatory fluency, and sensory performance.

• Market Cap: $17.25B

• Revenue mix, FY2024: Nourish 51.1%, Scent 21.2%, Health & Biosciences 19.3%, Pharma Solutions 8.4%.

• Key stats:

  • TTM revenue: $11,072m. TTM gross margin: 36.4%. TTM net income: -$472m. Period ends Q3 2025.

  • Net debt: $5.5B at 9/30/2025, down from $8.5B at 12/31/2024.

  • Employees: about 22,400. Industry: Specialty Chemicals, flavors and fragrances.

  • Market cap changes daily. Treat it as context, not a decision anchor.

Company History

• 1958: IFF formed, building on early European flavor and fragrance houses.

• 1960s: Lists on NYSE.

• 2018: Buys Frutarom, expanding naturals and SMB reach.

• 2021: Completes Reverse Morris Trust merger with DuPont Nutrition & Biosciences, creating a broader ingredients platform.

• 2022: Sells Microbial Control for about $1.3b, starts portfolio simplification.

• 2023: Destocking and inflation hangover drive impairments and restructuring.

• 2024: Pharma Solutions classified as held for sale. Cosmetic Ingredients exits. Additional impairment and held-for-sale charges hit GAAP results.

• 2025: Closes Pharma Solutions sale to Roquette. Uses proceeds to tender debt and compress leverage.

Show Me the Money

Stand-out financial features*

• Leverage is trending down. Net debt fell from $8.53B at 12-31-2024 to $5.46B by 9-30-2025 after divestiture proceeds and debt tenders.

• R&D is meaningful. R&D was 5.8% of sales in 2024 and 6.3% in 9M 2025, supporting future pipeline wins.

• Capex re-accelerated. TTM capex is 5.1% of sales, tied to plants and application labs.

• GAAP volatility masks underlying progress. Gross margin improved with pricing and productivity even as impairments and portfolio clean-up pulled operating margin negative on a TTM basis.

Financial Data

The N.O.O.B. Nine — Competitive Powers

The Nerd Out on Business Nine is made up of Hamliton Helmer's famous "7 Powers" of competitive advantage (Scale Economies, Network Economies, Counter-Positioning, Switching Costs, Branding, Cornered Resource, and Process Power) combined with two of my own (Data Flywheel and Distribution Advantage).

Average Score: 3/5 - Average of 9 competitive powers. Strong areas include powers scoring 4+ points, while areas scoring below 3 may need strategic attention.

Memorable Marketing

• Approach: Position as a science-backed co-creation partner, not a commodity supplier. Win briefs with application labs, trend intelligence, and rapid prototyping.

• Tastepoint by IFF, 2017

  • Core idea: A distinct brand for emerging and mid-market food brands with faster briefs and lower MOQs.

  • Primary channels: trade shows, targeted email, local application labs, webinars

  • Why it worked: Clear ICP, service-level promises, and proximity labs reduce time-to-sample and decision friction.

  • Result: Greater SMB penetration and a feeder into enterprise relationships.

• Re-Imagine Protein, 2019 to 2024

  • Core idea: Co-creation sprints for plant-based, dairy-alternative, and nutrition applications using texture systems, masking, and proteins.

  • Primary channels: innovation challenges, technical content, lab sprints

  • Why it worked: Big category need, pre-built building blocks, tight brief structure, and quick iteration.

  • Result: Pipeline of trials across meat-alternative and nutrition categories plus reputational lift with scale-ups and investors.

• Scent Creative Centers, ongoing

  • Core idea: On-site perfumery and consumer testing that compresses months of back-and-forth into days.

  • Primary channels: in-person labs and customer immersion sessions

  • Why it worked: Sensory theater plus speed drives higher spec-in odds for new launches.

  • Result: Better close rates on new fragrance briefs.

Tactical takeaways for founders

1. Run micro-sprints with customers in your lab or kitchen, then price for speed.

2. Publish a yearly trend brief and ship ready-to-test kits that make decisions easy.

3. Offer a fast-lane service tier with short lead times and small MOQs.

4. Treat demos as theater so buyers feel the product, not just read specs.

AI Uses & Opportunities

• Current state: Filings do not detail broad AI deployments. Productivity programs and portfolio analytics imply early foundations rather than scaled AI.

• Near-term, high-ROI ideas

  • Predictive formulation assistants trained on prior briefs and sensory data to suggest base formulas and cost-optimized swaps.

  • Digital olfaction and taste mapping with e-nose and e-tongue sensors to pre-screen prototypes before panels.

  • Price-through engines that blend commodity curves and transaction history to set customer-specific ladders that protect gross margin.

  • Plant scheduling co-pilots that optimize run sequencing under allergen and cleanup constraints to raise utilization.

  • Brief triage using similarity search to route incoming requests to the right application chemists.

Bumps in the Road

• Regulatory scrutiny: Global fragrance suppliers faced antitrust investigations. IFF has faced class-action litigation in the United States and has moved toward settlement while denying wrongdoing.

• Impairments: Large goodwill and asset-sale charges in 2022 to 2025 depressed GAAP earnings and operating profit.

• Leverage risk: Post-merger leverage and covenant pressure forced asset sales and limited flexibility.

• Demand volatility: De-stocking and price elasticity created uneven volumes across 2023 to 2025.

Your Swipe File

• Co-creation of formulations adds value to customers while adding stickiness. Look for opportunities do the same with your customers, if it isn’t too expensive.

• Separate a fast-lane brand for SMBs. A lighter offering can unlock a segment your main brand neglects.

• Codify price-through rules tied to inputs. Pre-agree triggers for price changes to protect gross margin.

• Approach debt with caution.

• Publish trend maps with starter kits. Make it effortless for customers to test and decide inside a week.